EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Track record

Tools

  • Compare
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›SLSN

SLSN

SOLESENCE, INC.

Next earnings Jul 29, 2026

Last earnings +2.5% on 2026-05-12

Hold
$0.83
▼ -21.05%
$0.83▼ -84.17%
over 1Y
L $0.81EODHDH $5.21
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-21.1%
1W-21.4%
1M-32.9%
3M-9.3%
YTD-45.0%
1Y-84.2%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
C+
Valuation
Overvalued
Filings
Flagged
Hold
Conviction
Horizon
Medium (3–12mo)

Revenue grew 18.6% YoY; but thin net margin (2.9%).

The read

Middling fundamentals and a rich price (~80% above fair value) leave little margin of safety — a wait-and-see.

SOLESENCE, INC. shows $62.1M in FY2025 revenue (+18.6% YoY), a 2.9% net margin, and 10.2% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$29.5M$37.3M$37.3M$52.3M$62.1M
Gross profit$8.69M$8.36M$7.83M$16.2M$16.1M
Operating income$2.56M-$2.26M-$3.55M$5.13M$1.57M
Net income$2.32M-$2.62M-$4.39M$4.24M$1.79M
Diluted EPS$0.05-$0.05-$0.09$0.07$0.02
Net margin7.9%-7.0%-11.8%8.1%2.9%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$58.5M
EV / EBITDA23.7
EV / Sales0.9
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield3.1%
FCF yield-22.5%

Quality & risk

ROIC (est.)6.5%
Free cash flow-$13.1M
Total debt$1.50M
Net cash-$212K
Piotroski F-Score4/9

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+0.8%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — restated periodic report (2026-04-23). Worth a closer look.
  1. 8-K Earnings results2026-05-12
  2. 10-Q Quarterly report2026-05-12
  3. 8-K Officer / director change2026-04-29
  4. 10-K/A Restated periodic report2026-04-23
  5. 8-K Earnings results2026-03-31
  6. 10-K Annual report2026-03-31
  7. 8-K Officer / director change2025-12-03
  8. 8-K Officer / director change2025-12-01
  9. 8-K Earnings results2025-11-13

Recent filings

all on EDGAR ↗
10-QPeriod ending 2026-03-312026-05-12open ↗8-KPeriod ending 2026-05-122026-05-12open ↗8-KPeriod ending 2026-04-242026-04-29open ↗10-K/APeriod ending 2025-12-312026-04-23open ↗10-KPeriod ending 2025-12-312026-03-31open ↗8-KPeriod ending 2026-03-312026-03-31open ↗4Period ending 2025-12-242025-12-30open ↗4Period ending 2025-11-142025-12-11open ↗8-KPeriod ending 2025-11-242025-12-03open ↗8-KPeriod ending 2025-11-212025-12-01open ↗8-KPeriod ending 2025-11-112025-11-13open ↗10-QPeriod ending 2025-09-302025-11-12open ↗

Quality score

C+
ValueGrowthProfitHealthMom.
ValueC+
GrowthD
ProfitabilityC-
Financial healthA-
Momentum—
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✗P/E below 25

Fair value est.

$0.16

Overvalued -80% vs price

cheapfair valueexpensive

Modified Graham: EPS $0.02 × (8.5 + 1.5 × 0.0% growth) × 0.95 quality = 8.1× multiple. An estimate, not a price target.

Revenue
$62.1M
+18.6% YoY
Net margin
2.9%
ROE
10.2%
P/E
41.3

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$62.1M+18.6%
Net income$1.79M-57.7%
Gross profit$16.1M-0.8%
Operating income$1.57M-69.4%
Diluted EPS$0.02-71.4%
Cash & equivalents$1.29M-8.6%
Total assets$50.1M+0.1%
Stockholders' equity$17.6M+18.0%
Gross: 25.9%Op.: 2.5%

Frequently asked

Is SOLESENCE, INC. (SLSN) a buy?
SLSN currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Revenue grew 18.6% YoY; but thin net margin (2.9%).
What is SLSN's fair value?
A Modified-Graham model based on SLSN's SEC fundamentals estimates a fair value of about $0.16. It is an estimate from reported earnings, not a price target.
Is SLSN overvalued or undervalued?
Against a Modified-Graham fair-value estimate, SLSN currently appears overvalued relative to its SEC-grounded earnings power.
What is SOLESENCE, INC.'s quality score?
SLSN scores 60.843137254901954/100 (grade C+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000883107, latest 10-Q filed 2026-05-12) · EODHD · as of 6/26/2026, 8:06:09 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2025-12-24
WHITMORE R JANET
Director
Buy1.50K @ $1.91$2.87K
2025-12-24
WHITMORE R JANET
Director
Buy1.00K @ $1.92$1.92K
2025-11-19
WHITMORE R JANET
Director
Buy5.00K @ $1.95$9.75K
2025-11-19
WHITMORE R JANET
Director
Buy5.00K @ $1.89$9.45K
2025-11-18
WHITMORE R JANET
Director
Buy267.00 @ $1.83$488.61
2025-11-17
WHITMORE R JANET
Director
Buy5.00K @ $1.87$9.35K
2025-11-14
WHITMORE R JANET
Director
Buy19.8K @ $1.73$34.2K
2025-06-06
Cureton Kevin
Chief Operating Officer
Exercise38.8K @ $0.42$16.3K
2025-06-06
Cureton Kevin
Chief Operating Officer
Sell38.8K @ $3.80$147K
2025-06-05
Cureton Kevin
Chief Operating Officer
Exercise4.69K @ $0.42$1.97K
2025-06-05
Cureton Kevin
Chief Operating Officer
Sell4.69K @ $3.96$18.6K
2025-05-29
WHITMORE BRADFORD T
10% owner
Buy2.50M @ $4.20$10.5M

Earnings history

beat/miss · move
2026-05-12—▼ -17.33%8-K ↗
2026-03-31—▲ +5.56%8-K ↗
2025-11-13—▼ -15.46%8-K ↗
2025-07-31—▼ -8.04%8-K ↗
2025-05-07—▲ +7.80%8-K ↗
2025-03-26——8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of RecognitionBullish
globenewswire.com· 2026-05-19
SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating CostsBullish
finance.yahoo.com· 2026-05-19
Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety CoalitionBullish
globenewswire.com· 2026-05-14
Solesence, Inc. Common Stock Q1 2026 Earnings Call SummaryBullish
finance.yahoo.com· 2026-05-12
Solesence (SLSN) Q1 2026 Earnings TranscriptBullish
nasdaq.com· 2026-05-12
Solesence, Inc. Common Stock Q4 2025 Earnings Call SummaryBullish
finance.yahoo.com· 2026-04-01

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score61 vs 67
Revenue growth18.6% vs 7.1%
Net margin2.9% vs 10.5%
Return on equity10.2% vs 12.3%
P/E41.3 vs 25.5

News sentiment

EODHD · 3d
Bullish
+0.18
vs typical · 5 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.